|
"jiaang wt"的相關文件
顯示項目 56-65 / 86 (共9頁)
<< < 1 2 3 4 5 6 7 8 9 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2012-01 |
Resistance analysis and characterization of a thiazole analogue, BP008, as a potent hepatitis C virus NS5A inhibitor
|
Lin, HM;Wang, JC;Hu, HS;Wu, PS;Yang, CC;Wu, CP;Pu, SY;Hsu, TA;Jiaang, WT;Chao, YS;Chern, JH;Yeh, TK;Yueh, A |
| 國家衛生研究院 |
2012-01 |
BPR1J-097, a novel FLT3 kinase inhibitor, exerts potent inhibitory activity against AML
|
Lin, WH;Jiaang, WT;Chen, CW;Yen, KJ;Hsieh, SY;Yen, SC;Chen, CP;Chang, KY;Chang, CY;Chang, TY;Huang, YL;Yeh, TK;Chao, YS;Chen, CT;Hsu, JT |
| 國家衛生研究院 |
2011-12-06 |
Pyrrolidine compounds
|
Jiaang, WT;Chen, X |
| 國家衛生研究院 |
2011-09-20 |
Pyrrolidine derivatives
|
Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T |
| 國家衛生研究院 |
2011-07 |
Discovery and evaluation of 3-phenyl-1H-5-pyrazolylamine-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)
|
Lin, WH;Hsieh, SY;Yen, SC;Chen, CT;Yeh, TK;Hsu, T;Lu, CT;Chen, CP;Chen, CW;Chou, LH;Huang, YL;Cheng, AH;Chang, YI;Tseng, YJ;Yen, KR;Chao, YS;Hsu, JT;Jiaang, WT |
| 國家衛生研究院 |
2011-06 |
Cleavage-site specificity of prolyl endopeptidase FAP investigated with a full-length protein substrate
|
Huang, CH;Suen, CS;Lin, CT;Chien, CH;Lee, HY;Chung, KM;Tsai, TY;Jiaang, WT;Hwang, MJ;Chen, X |
| 國家衛生研究院 |
2011-06 |
Current advances and therapeutic potential of agents targeting dipeptidyl peptidases-IV, -II, 8/9 and fibroblast activation protein
|
Chen, SJ;Jiaang, WT |
| 國家衛生研究院 |
2011-05-25 |
Pyrrolidine derivatives
|
Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T |
| 國家衛生研究院 |
2011-02 |
Synthesis of 3,3-dimethylglutamic acid derivatives as DPP-IV inhibitors and evaluation of their chemical stability
|
Hsu, T;Tsai, TY;Tseng, YJ;Chiou, MC;Lu, CT;Chao, YS;Jiaang, WT |
| 國家衛生研究院 |
2010-10-06 |
吡咯烷化合物
|
Jiaang, WT;Chen, X;Wu, SY;Hsieh, HP;Chao, YS |
顯示項目 56-65 / 86 (共9頁)
<< < 1 2 3 4 5 6 7 8 9 > >>
每頁顯示[10|25|50]項目
|
